Science for Healthy Longevity

At Lateral Pharma, we believe the future of medicine should not only be defined by the progress made in laboratories, but by the difference it makes in the real world. For patients, families and communities living with complex conditions, every advance in treatment has the potential to bring life-changing results. 

This is why we are dedicated to redefining what’s possible with biotechnology. By unlocking the body’s natural protective pathways, we are developing first-in-class therapeutics which address some of the greatest challenges in healthcare today.

Founded in Melbourne, Lateral Pharma is an Australian biotechnology company dedicated to translating scientific discovery into therapies that transform lives. Our innovation centres on LanC-like (LanCL) proteins, which naturally protect cells from stress, inflammation, and damage. By targeting these pathways, we are creating a new generation of medicines for patients with limited options.

With clinical validation and a strong safety record, our lead candidates are advancing towards real-world impact. LAT8881 has already been tested in more than 700 patients, showing safety, tolerability, and, in a recent clinical trial measurable clinical benefit in lumbar radicular pain (sciatica). LAT9997*, our next-generation compound, offers enhanced scalability and potential for widespread use. Data from these programs demonstrate the strength of our platform and the promise of LanCL-targeting therapies.